Question

What is the primary therapeutic use of Raloxifene (brand name: Evista)?

Options:

Treatment of osteoporosis in postmenopausal women.
Management of hypertension in adults.
Relief of acute pain in arthritis patients.
Prevention of migraines in women of reproductive age.

Answer 1

The primary therapeutic use of Raloxifene (brand name: Evista) is the treatment of osteoporosis in postmenopausal women.

Step-by-step explanation:

The primary therapeutic use of Raloxifene (brand name: Evista) is the treatment of osteoporosis in postmenopausal women. Osteoporosis is a condition where the bones become weak and brittle, making them more prone to fractures. Raloxifene is a medication that belongs to a class of drugs called selective estrogen receptor modulators (SERMs), and it works by mimicking the effects of estrogen in the body. It helps to increase bone density and reduce the risk of fractures in postmenopausal women.